Revvity Operating Income 2010-2024 | RVTY

Revvity annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Revvity operating income for the quarter ending September 30, 2024 was $0.098B, a 41.78% increase year-over-year.
  • Revvity operating income for the twelve months ending September 30, 2024 was $0.305B, a 15.44% decline year-over-year.
  • Revvity annual operating income for 2023 was $0.301B, a 59.53% decline from 2022.
  • Revvity annual operating income for 2022 was $0.743B, a 40.98% decline from 2021.
  • Revvity annual operating income for 2021 was $1.258B, a 45.11% increase from 2020.
Revvity Annual Operating Income
(Millions of US $)
2023 $301
2022 $743
2021 $1,258
2020 $867
2019 $362
2018 $324
2017 $296
2016 $295
2015 $251
2014 $165
2013 $228
2012 $103
2011 $91
2010 $158
2009 $116
Revvity Quarterly Operating Income
(Millions of US $)
2024-09-30 $98
2024-06-30 $86
2024-03-31 $44
2023-12-31 $77
2023-09-30 $69
2023-06-30 $78
2023-03-31 $76
2022-12-31 $137
2022-09-30 $111
2022-06-30 $232
2022-03-31 $262
2021-12-31 $263
2021-09-30 $196
2021-06-30 $332
2021-03-31 $468
2020-12-31 $399
2020-09-30 $248
2020-06-30 $176
2020-03-31 $45
2019-12-31 $138
2019-09-30 $79
2019-06-30 $92
2019-03-31 $53
2018-12-31 $116
2018-09-30 $80
2018-06-30 $88
2018-03-31 $40
2017-12-31 $94
2017-09-30 $78
2017-06-30 $74
2017-03-31 $50
2016-12-31 $92
2016-09-30 $76
2016-06-30 $66
2016-03-31 $61
2015-12-31 $50
2015-09-30 $76
2015-06-30 $68
2015-03-31 $57
2014-12-31 $-15
2014-09-30 $59
2014-06-30 $70
2014-03-31 $52
2013-12-31 $94
2013-09-30 $58
2013-06-30 $40
2013-03-31 $36
2012-12-31 $-26
2012-09-30 $43
2012-06-30 $50
2012-03-31 $36
2011-12-31 $-26
2011-09-30 $36
2011-06-30 $39
2011-03-31 $41
2010-12-31 $52
2010-09-30 $41
2010-06-30 $33
2010-03-31 $31
2009-12-31 $31
2009-09-30 $22
2009-06-30 $38
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00